Latest Patents News

Everest Metals Corporation (ASX: EMC) has upgraded its Mt Edon Critical Minerals Project resource to 4.3 million tonnes at 0.23% Rb2O, enhancing grade, tonnage, and confidence ahead of a mining proposal submission expected to gain approval by late 2026.

Anson Resources' scoping study for its Green River Lithium Project in Utah reveals first quartile operating costs and a clear development pathway targeting 10,000 tonnes per annum lithium carbonate production by 2029.

TG Metals is accelerating development at its Lake Johnston Lithium Project amid improved lithium prices, with mining lease applications and resource drilling approvals underway for the Burmeister deposit.

Atomo Diagnostics has closed a modest Share Purchase Plan, raising $44,500 and issuing free attaching options, while reserving a substantial shortfall for future placement.

Archer Materials progresses its Biosensor platform from alpha to beta prototype, targeting manufacturability and external validation with expanded diagnostic applications including lithium monitoring.

Syntara Limited offers existing shareholders a discounted share purchase plan to raise about $2 million, following a recent $8 million institutional placement to fund clinical trials and licensing.

Advanced Energy Minerals is ramping up its Quebec high purity alumina plant to 3,000 tpa by mid-2026, with plans to double capacity to 6,000 tpa by 2029 amid a tightening global market and supply deficit.

Bayan Mining and US Critical Materials have signed a non-binding MoU to develop rare-earth processing technologies licensed from the Colorado School of Mines, targeting high-grade mineralisation at the Sheep Creek Project in Montana. The collaboration aims to support a US-based rare earth supply chain with potential strategic investment on the horizon.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.

American West Metals has published a detailed JORC 2012-compliant Mineral Resource Estimate for its West Desert Zinc-Copper-Indium-Magnetite Project in Utah, affirming solid resource continuity and robust sampling techniques.